Invention Grant
- Patent Title: Molecules with specificity for CD45 and CD79
-
Application No.: US15326499Application Date: 2015-07-16
-
Publication No.: US10774152B2Publication Date: 2020-09-15
- Inventor: Helene Margaret Finney , Stephen Edward Rapecki , Michael John Wright , Kerry Louise Tyson
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@31ec3adb
- International Application: PCT/EP2015/066368 WO 20150716
- International Announcement: WO2016/009029 WO 20160121
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; C07K16/18 ; C07K16/46
Abstract:
The present disclosure relates to a multispecific molecule comprising a binding domain specific to the antigen CD45 and a binding domain specific to the antigen CD79a and/or CD79b, compositions comprising same and use of each in treatment, for example treatment of autoimmune disease.
Public/Granted literature
- US10730952B2 Molecules with specificity for CD45 and CD79 Public/Granted day:2020-08-04
Information query
